Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

61. Cohort study: About half of children under age 3 whose parents suspected acute otitis media do not have the diagnosis; restless sleep, ear rubbing, crying, irritability and fever are not predictive

Cohort study: About half of children under age 3 whose parents suspected acute otitis media do not have the diagnosis; restless sleep, ear rubbing, crying, irritability and fever are not predictive About half of children under age 3 whose parents suspected acute otitis media do not have the diagnosis; restless sleep, ear rubbing, crying, irritability and fever are not predictive | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use (...) of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here About half of children under age 3 whose parents suspected acute otitis media do not have the diagnosis; restless sleep, ear

Evidence-Based Medicine (Requires free registration)2010

62. Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis

Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis Courter JD, Baker WL, Nowak KS, Smogowicz LA, Desjardins LL, Coleman CI, Girotto JE CRD summary The review found that paediatric patients with acute otitis media and treated with macrolide antibiotics compared (...) to first-line antibiotics may be more likely to have clinical failures. The authors' conclusions reflect the evidence presented, but limitations in the quality of many of the included studies mean the conclusions should be considered tentative. Authors' objectives To assess whether clinical failure is more likely with macrolide antibiotics when compared to first line oral agents in children with acute otitis media. Searching MEDLINE, EMBASE and IPA were searched from inception to end of September 2008

DARE.2010

64. Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial

Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial Petrou S, Dakin H, Abangma G, Benge S, Williamson I Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study assessed the cost-effectiveness of topical intranasal steroids for the treatment of otitis media with effusion. The authors concluded that topical steroids were unlikely to be cost-effective in general practice, but the value of information analysis suggested

NHS Economic Evaluation Database.2010

65. Management of acute otitis media: update

Management of acute otitis media: update Management of acute otitis media: update Management of acute otitis media: update Shekelle PG, Takata G, Newberry SJ, Coker T, Limbos M, Chan LS, Timmer M, Suttorp M, Carter J, Motala A, Valentine D, Johnsen B, Shanman R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Shekelle PG, Takata G (...) , Newberry SJ, Coker T, Limbos M, Chan LS, Timmer M, Suttorp M, Carter J, Motala A, Valentine D, Johnsen B, Shanman R. Management of acute otitis media: update. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 198. 2010 Authors' conclusions Few studies were found that examined the accuracy and precision of the diagnosis of AOM. Since PCV7's introduction, AOM microbiology has shifted significantly, with Streptococcus pneumoniae becoming less prevalent

Health Technology Assessment (HTA) Database.2010

66. Management of acute otitis media: update

Management of acute otitis media: update Management of acute otitis media: update Management of acute otitis media: update Shekelle PG, Takata G, Newberry SJ, Coker T, Limbos MA, Chan LS, Timmer MM, Suttorp MJ, Carter J, Motala A, Valentine D, Johnsen B, Shanman R CRD summary The authors concluded that immediate antibiotic therapy was more effective than placebo for treating uncomplicated acute otitis media. Comparison of different antibiotic treatments was inconclusive for recurrent otitis (...) media. Further research is needed. The authors' conclusions reflected the evidence, but given significant heterogeneity and concerns regarding the analysis, their conclusions should be interpreted with caution. Authors' objectives To update a 2001 review to assess the effectiveness of different treatments for uncomplicated acute otitis media in average risk children and children with recurrent or persistent acute otitis media. Searching PubMed, Cochrane Central Register of Controlled Trials (CENTRAL

DARE.2010

67. Efficacy of short course (<4 days) of antibiotics for treatment of acute otitis media in children: a systematic review of randomized controlled trials

Efficacy of short course (<4 days) of antibiotics for treatment of acute otitis media in children: a systematic review of randomized controlled trials Efficacy of short course (<4 days) of antibiotics for treatment of acute otitis media in children: a systematic review of randomized controlled trials Efficacy of short course (<4 days) of antibiotics for treatment of acute otitis media in children: a systematic review of randomized controlled trials Gulani A, Sachdev HP, Qazi SA CRD summary (...) This review found no evidence of increased risk of treatment failure with short-course (<4 days) compared with long-course (≥4 days) antibiotics for acute otitis media in children. The authors' conclusions are likely to be reliable, but should be interpreted with some caution due to a lack of detail on searches, quality assessment and individual study features. Authors' objectives To determine the efficacy of a short course of antibiotics (less than four days) compared to a longer course (four or more

DARE.2010

68. Antibiotics for Otitis Media

Antibiotics for Otitis Media Antibiotics for Otitis Media – TheNNTTheNNT Antibiotics for Acute Otitis Media No benefit found In Summary, for those who took the antibiotics: Benefits in NNT 100% saw no benefit (reduction of serious complications: mastoiditis, meningitis, hearing loss) 100% saw no benefit (reduced late recurrence) 100% saw no benefit (pain reduction after 24 hours) 6% had reduced pain (after 2-7 days) None had fewer serious complications None had less disease recurrence None had (...) less pain after 24 hours 1 in 16 were helped (pain reduction after 2-7 days) Harms in NNT 11% were harmed (diarrhea) 1 in 9 were harmed (diarrhea) View As: NNT % Source: Efficacy Endpoints: Serious complications (mastoiditis, meningitis, hearing loss), disease recurrence, pain Harm Endpoints: Adverse medication effects Narrative: This review included 15 trials (n = 4199 children) of which 10 (n = 2928) compared antibiotics with placebo in patients with acute otitis media. Amoxicillin and penicillin

theNNT2010

69. A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care

A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please

NIHR HTA programme2009

70. Adapting your practice: treatment and recommendations for homeless children with otitis media.

Adapting your practice: treatment and recommendations for homeless children with otitis media. Adapting your practice: treatment and recommendations for homeless children with otitis media. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:006943 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's

Health Care for the Homeless (HCH) Clinician's Network2009

71. Pneumococcal conjugate vaccines for preventing otitis media.

Pneumococcal conjugate vaccines for preventing otitis media. BACKGROUND: Acute otitis media (AOM) is a very common early infancy and childhood disease. The marginal benefits of antibiotics on AOM, the increasing problem of bacterial resistance to antibiotics, and the huge estimated direct and indirect annual costs associated with otitis media (OM) have prompted a search for effective vaccines to prevent AOM. OBJECTIVES: To assess the effect of pneumococcal conjugate vaccines (PCVs

Cochrane2009

73. New vaccines against otitis media: projected benefits and cost-effectiveness

New vaccines against otitis media: projected benefits and cost-effectiveness New vaccines against otitis media: projected benefits and cost-effectiveness New vaccines against otitis media: projected benefits and cost-effectiveness O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study assessed three vaccines, compared with no vaccination, for preventing acute otitis media in infants and young children. The authors found that these vaccines could prevent millions of acute otitis media episodes and pneumococcal non-typeable Haemophilus influenzae vaccine could be cost-effective, compared with heptavalent

NHS Economic Evaluation Database.2009

74. Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials

Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials Vouloumanou EK, Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, Falagas ME CRD summary This review concluded that antibiotic treatment (...) was associated with a more favourable clinical course in children with acute otitis media compared to placebo or watchful waiting, but that the treatment effect was relatively small. The conclusion reflects the results of the review and, despite some limitations in the review process and reporting, is probably reliable. Authors' objectives To evaluate the role of prescribing antibiotics for acute otitis media. Searching PubMed and The Cochrane Library were searched up to March 2009. References of relevant

DARE.2009

75. A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care

A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children with persistent bilateral otitis media with effusion in primary care A double-blind randomised placebo controlled trial of topical intranasal corticosteroids in 4- to11-year-old children (...) with persistent bilateral otitis media with effusion in primary care Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Abangma G, Dakin H, Little P Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, Abangma G, Dakin H, Little P. A double-blind randomised placebo controlled trial

Health Technology Assessment (HTA) Database.2009

76. Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants.

Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. 19567910 2009 07 01 2009 07 16 2014 12 07 1756-1833 338 2009 Jun 30 BMJ (Clinical research ed.) BMJ Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. b2525 10.1136/bmj.b2525 bmj.b2525 To determine the long term effects of antibiotic treatment for acute otitis media in young (...) children. Prospective three year follow-up study within the framework of a primary care based, double blind, randomised, placebo controlled trial. 53 general practices in the Netherlands. 168 children aged 6 months to 2 years with acute otitis media. Amoxicillin 40 mg/kg/day in three doses compared with placebo. Recurrence of acute otitis media; referral to secondary care; ear, nose, and throat surgery. Acute otitis media recurred in 63% (47/75) of children in the amoxicillin group and in 43% (37/86

BMJ2009 Full Text: Link to full Text with Trip Pro

77. Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial.

Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial. 20015903 2009 12 17 2009 12 29 2016 11 22 1756-1833 339 2009 Dec 16 BMJ (Clinical research ed.) BMJ Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial. b4984 10.1136/bmj.b4984 bmj.b4984 (...) To determine the clinical effectiveness of topical intranasal corticosteroids in children with bilateral otitis media with effusion. Double blind randomised placebo controlled trial. 76 Medical Research Council General Practice Research Framework practices throughout the United Kingdom, between 2004 and 2007. 217 children aged 4-11 years who had at least one practice recorded episode of otitis media or a related ear problem in the previous 12 months, and with bilateral otitis media with effusion confirmed

BMJ2009 Full Text: Link to full Text with Trip Pro

79. Grommets (ventilation tubes) for recurrent acute otitis media in children.

Grommets (ventilation tubes) for recurrent acute otitis media in children. BACKGROUND: Acute suppurative otitis media is one of the most common infectious diseases in childhood. Recurrent acute otitis media is defined for the purposes of this review as either three or more acute infections of the middle ear cleft in a six-month period, or at least four episodes in a year. Strategies for managing the condition include the assessment and modification of risk factors where possible, repeated (...) courses of antibiotics for each new infection, antibiotic prophylaxis and the insertion of ventilation tubes (grommets). OBJECTIVES: To establish whether ventilation tube insertion reduces the frequency of episodes of recurrent acute otitis media and the proportion of children with symptoms of ear disease. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1 2008

Cochrane2008

80. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media.

Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. BACKGROUND: Acute otitis media (AOM) is a common problem in children, for which the antibiotic amoxicillin, with or without clavulanate, is frequently prescribed. OBJECTIVES: To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children. SEARCH STRATEGY: We searched

Cochrane2008